Addus HomeCare (NASDAQ:ADUS) EVP Sean Gaffney Sells 442 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Sean Gaffney sold 442 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $46,569.12. Following the completion of the sale, the executive vice president owned 20,080 shares in the company, valued at $2,115,628.80. This represents a 2.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Sean Gaffney also recently made the following trade(s):

• On Tuesday, February 24th, Sean Gaffney sold 817 shares of Addus HomeCare stock. The stock was sold at an average price of $106.98, for a total value of $87,402.66.

Addus HomeCare Stock Performance

ADUS traded down $0.51 during trading hours on Friday, reaching $103.52. The company’s stock had a trading volume of 14,471 shares, compared to its average volume of 233,037. The company’s 50-day moving average is $109.41 and its 200-day moving average is $113.01. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $124.43. The firm has a market cap of $1.92 billion, a PE ratio of 19.85, a price-to-earnings-growth ratio of 1.49 and a beta of 0.91. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds have recently bought and sold shares of the company. Invesco Ltd. lifted its holdings in shares of Addus HomeCare by 7.1% during the 4th quarter. Invesco Ltd. now owns 416,857 shares of the company’s stock worth $44,766,000 after acquiring an additional 27,683 shares during the period. Caitlin John LLC acquired a new position in Addus HomeCare during the fourth quarter valued at approximately $183,000. Empowered Funds LLC lifted its stake in Addus HomeCare by 186.1% during the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after purchasing an additional 46,137 shares during the last quarter. XTX Topco Ltd bought a new stake in shares of Addus HomeCare during the 4th quarter worth $432,000. Finally, VARCOV Co. acquired a new stake in Addus HomeCare in the fourth quarter valued at about $382,000. 95.35% of the stock is owned by institutional investors.

Addus HomeCare News Summary

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. TD Cowen restated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Stephens lowered their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. Barclays reduced their target price on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a research report on Tuesday. Finally, Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $134.33.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.